Label: IMG- phellinus linteus mycelium tablet
-
Contains inactivated NDC Code(s)
NDC Code(s): 53144-3001-1 - Packager: Yein Trading & Global Co., Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated February 26, 2013
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
-
INACTIVE INGREDIENT
Zinc gluconate 3% (14.34% as Zinc), Vitamin C 10% (100% as vitamin C), Lactose 41%, Cordyceps militaris extract powder (mycelium culture) 6%, Chaga mushroom extract powder (mycelium culture) 6%, Ganoderma lucidum extract powder (mycelium culture) 6%, Trametes versicolor extract powder (mycelium culture) 6%, Grifola frondosa (mycelium culture) 6%, Hydroxypropylmethyl-cellulose 4%, Cultured Wild ginseng root powder 3%, Carboxymethylcellulose calcium 2%, Magnesium stearate 1%
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
-
INDICATIONS & USAGE
1. ulterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver
- WARNINGS
-
DOSAGE & ADMINISTRATION
- uterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication : as a phellinus linteus mycelia extracts, administer 550~1100mg 2 times per a day before having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver : as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
IMG
phellinus linteus mycelium tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:53144-3001 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHELLINUS LINTEUS MYCELIUM (UNII: 40K19XJV3C) (PHELLINUS LINTEUS MYCELIUM - UNII:40K19XJV3C) PHELLINUS LINTEUS MYCELIUM 0.022 Inactive Ingredients Ingredient Name Strength ZINC GLUCONATE (UNII: U6WSN5SQ1Z) ASCORBIC ACID (UNII: PQ6CK8PD0R) LACTOSE (UNII: J2B2A4N98G) REISHI (UNII: TKD8LH0X2Z) TRAMETES VERSICOLOR FRUITING BODY (UNII: 4C900477MT) GRIFOLA FRONDOSA WHOLE (UNII: O238UC53ET) HYPROMELLOSES (UNII: 3NXW29V3WO) CARBOXYMETHYLCELLULOSE CALCIUM (UNII: UTY7PDF93L) MAGNESIUM STEARATE (UNII: 70097M6I30) Product Characteristics Color brown (light brown) Score no score Shape OVAL (pill) Size 15mm Flavor Imprint Code 3;hp;x Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:53144-3001-1 60 in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/16/2013 Labeler - Yein Trading & Global Co., Ltd (557803795) Registrant - Yein Trading & Global Co., Ltd (557803795) Establishment Name Address ID/FEI Business Operations Han Kook Sin Yak Pharmaceutical Co., Ltd. 689277536 manufacture(53144-3001)